Antitrust litigation filed against Dr Reddy's Laboratories, other generic pharma companies in US https://ift.tt/h3UCuvJ

The complaint, which purports to be on behalf of a class of indirect purchasers, asserts claims under federal and state antitrust laws and other state laws alleging that the defendants improperly restrained competition and maintained a shared monopoly in the sale of brand and generic Revlimid through their respective settlements of patent litigation: Dr Reddy's Laboratories

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/1u8MCZb